BPG is committed to discovery and dissemination of knowledge
Review
©2012 Baishideng.
World J Psychiatr. Oct 22, 2012; 2(5): 74-82
Published online Oct 22, 2012. doi: 10.5498/wjp.v2.i5.74
Table 1 Adherence evaluation methods
DirectIndirect
Detection of the drug or drug metabolitesObjective
Direct observationTablet count
Electronic monitoring
Pharmacy records
Subjective
Psychometric scales
Questioning the patient
Questioning the relatives
Clinical judgment
Table 2 Identified risk factors for non-adherence by patients with schizophrenia
Patient-related risk factors
Sociodemographic factors
Younger and older patients
Male
General clinical factors
Drugs or alcohol consumption
Previous non-adherence
Psychopathological symptoms
Impaired insight
Cognitive deficiency
Delusion of persecution, poisoning or grandeur
Psychotic symptoms
Negative symptoms
Psychological factors: attitudes, beliefs and other subjective aspects
Negative attitude toward the treatment
Negative subjective response to treatment
Regarding the disease as mild and/or perceived minor benefit from treatment
Shame or stigmatization associated with the medication or the disease
Environment-related risk factors
Poor social and familial support
Negative social perception of the disease
Stigmatization
Difficulty accessing healthcare services
Physician-related risk factors
Poor relationship with the therapist
Poor psychoeducation and information to patients and relatives
Poor contact with the therapist
Inadequate planning of the post-discharge period
Treatment-related risk factors
Ineffectiveness against persistent symptoms (psychotic and negative symptoms)
Fear of adverse effects
Complex medication schedule
Poorer adherence to oral than to intramuscular treatments


Write to the Help Desk